• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因多态性与家族性癌症风险增加相关:一项荟萃分析的证据。

polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis.

作者信息

Jiang Yan, Zhao Chen-Yang, Cheng Li-Chun, Xu Bing, Lv Hui-Yi

机构信息

Department of Pharmaceuticals, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116027 People's Republic of China.

出版信息

Hered Cancer Clin Pract. 2017 Jun 13;15:8. doi: 10.1186/s13053-017-0068-7. eCollection 2017.

DOI:10.1186/s13053-017-0068-7
PMID:28630657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5470195/
Abstract

Adenosine diphosphate (ADP)-ribosylation factor-like tumour suppressor gene 1() might be associated with an increased risk of several types of familial cancers. However, previous studies have shown that cancer susceptibility is not completely consistent with polymorphisms, and the precise mechanism remains unknown. Therefore, we conducted a meta-analysis of case-control studies by searching the PubMed, Embase, OVID, Science Direct and Chinese National Knowledge Infrastructure (CNKI) databases. In total, 12 studies met the inclusion criteria and were included in this meta-analysis. Statistical analyses were performed using STATA 11.0 software. Overall, the Cys148Arg T > C variant significantly increased cancer risk (CC vs. TT: OR = 1.27, 95% CI = 1.15-1.41,  < 0.05). The stratification indicated that the Cys148Arg variant is significantly associated with sporadic cancer (CC vs. TT: OR = 1.36, 95% CI = 1.18-1.55) and familial cancer (CC vs. TT: OR = 1.26, 95% CI = 1.12-1.43). Trp149Stop, Pro131Leu, Ser99Ser and Leu132Leu were not correlated with cancer susceptibility. Based on these results, we demonstrated that the Cys148Arg polymorphism is associated with an increased risk of sporadic cancer and familial cancer, and there were no associations between the other four SNPs (i.e., Trp149Stop, Pro131Leu, Ser99Ser and Leu132Leu) and cancer risk.

摘要

二磷酸腺苷(ADP)-核糖基化因子样肿瘤抑制基因1()可能与多种类型的家族性癌症风险增加有关。然而,先前的研究表明,癌症易感性与多态性并不完全一致,确切机制仍不清楚。因此,我们通过检索PubMed、Embase、OVID、Science Direct和中国国家知识基础设施(CNKI)数据库,对病例对照研究进行了荟萃分析。共有12项研究符合纳入标准并被纳入本荟萃分析。使用STATA 11.0软件进行统计分析。总体而言,Cys148Arg T>C变体显著增加了癌症风险(CC与TT相比:OR = 1.27,95%CI = 1.15 - 1.41,<0.05)。分层分析表明,Cys148Arg变体与散发性癌症(CC与TT相比:OR = 1.36,95%CI = 1.18 - 1.55)和家族性癌症(CC与TT相比:OR = 1.26,95%CI = 1.12 - 1.43)显著相关。Trp149Stop、Pro131Leu、Ser99Ser和Leu132Leu与癌症易感性无关。基于这些结果,我们证明Cys148Arg多态性与散发性癌症和家族性癌症风险增加有关,而其他四个单核苷酸多态性(即Trp149Stop、Pro131Leu、Ser99Ser和Leu132Leu)与癌症风险之间没有关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab18/5470195/b593790720d2/13053_2017_68_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab18/5470195/75a53defdb72/13053_2017_68_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab18/5470195/63ee2887f535/13053_2017_68_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab18/5470195/75a0a385549c/13053_2017_68_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab18/5470195/fd9f5b9c174b/13053_2017_68_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab18/5470195/b593790720d2/13053_2017_68_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab18/5470195/75a53defdb72/13053_2017_68_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab18/5470195/63ee2887f535/13053_2017_68_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab18/5470195/75a0a385549c/13053_2017_68_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab18/5470195/fd9f5b9c174b/13053_2017_68_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab18/5470195/b593790720d2/13053_2017_68_Fig5_HTML.jpg

相似文献

1
polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis.基因多态性与家族性癌症风险增加相关:一项荟萃分析的证据。
Hered Cancer Clin Pract. 2017 Jun 13;15:8. doi: 10.1186/s13053-017-0068-7. eCollection 2017.
2
Association of the ARLTS1 variants with familial ovarian cancer risk in China.中国ARLTS1基因变异与家族性卵巢癌风险的关联
Int J Gynecol Cancer. 2009 May;19(4):585-90. doi: 10.1111/IGC.0b013e3181a39d03.
3
Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk.ARLTS1基因Cys148Arg变异与家族性乳腺癌风险的关联。
Int J Cancer. 2006 May 15;118(10):2505-8. doi: 10.1002/ijc.21687.
4
Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.ARLTS1 Cys148Arg(T442C)变体与前列腺癌风险的关系及在前列腺癌细胞中的功能。
PLoS One. 2011;6(10):e26595. doi: 10.1371/journal.pone.0026595. Epub 2011 Oct 20.
5
ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer.ARLTS1 种系变异与乳腺癌、前列腺癌和结直肠癌风险
Eur J Hum Genet. 2008 Aug;16(8):983-91. doi: 10.1038/ejhg.2008.43. Epub 2008 Mar 12.
6
Familial cancer associated with a polymorphism in ARLTS1.与ARLTS1基因多态性相关的家族性癌症。
N Engl J Med. 2005 Apr 21;352(16):1667-76. doi: 10.1056/NEJMoa042280.
7
ARLTS1 variants and risk of colorectal cancer.ARLTS1基因变异与结直肠癌风险
Cancer Lett. 2006 Dec 8;244(2):172-5. doi: 10.1016/j.canlet.2005.12.006. Epub 2006 Feb 20.
8
Association of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer.ARLTS1基因Cys148Arg变异与散发性及家族性结直肠癌的关联
Carcinogenesis. 2007 Aug;28(8):1687-91. doi: 10.1093/carcin/bgm098. Epub 2007 Apr 21.
9
ARLTS1 variants and melanoma risk.
Int J Cancer. 2006 Oct 1;119(7):1736-7. doi: 10.1002/ijc.22008.
10
Cancer Familial Aggregation (CFA) and G446A polymorphism in ARLTS1 gene.癌症家族聚集性(CFA)与ARLTS1基因中的G446A多态性
Breast Cancer Res Treat. 2006 Sep;99(1):59-62. doi: 10.1007/s10549-006-9180-5. Epub 2006 Mar 29.

本文引用的文献

1
High resolution melting method to detect single nucleotide polymorphism of VKORC1 and CYP2C9.采用高分辨率熔解曲线法检测VKORC1和CYP2C9的单核苷酸多态性。
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2558-64. eCollection 2014.
2
The Arg98Trp mutation in human VKORC1 causing VKCFD2 disrupts a di-arginine-based ER retention motif.人类 VKORC1 中的 Arg98Trp 突变导致 VKCFD2 破坏基于二精氨酸的内质网保留基序。
Blood. 2014 Aug 21;124(8):1354-62. doi: 10.1182/blood-2013-12-545988. Epub 2014 Jun 24.
3
Identification of VKORC1 genotype leading to resistance to tecarfarin.
J Clin Pharmacol. 2014 Aug;54(8):896-900. doi: 10.1002/jcph.332.
4
Frequency of CYP2C9 and VKORC1 gene polymorphisms and their influence on warfarin dose in Egyptian pediatric patients.CYP2C9 和 VKORC1 基因多态性的频率及其对埃及儿科患者华法林剂量的影响。
Paediatr Drugs. 2014 Aug;16(4):337-41. doi: 10.1007/s40272-014-0073-5.
5
ARLTS1 and prostate cancer risk--analysis of expression and regulation.ARLTS1 与前列腺癌风险——表达与调控分析。
PLoS One. 2013 Aug 5;8(8):e72040. doi: 10.1371/journal.pone.0072040. Print 2013.
6
The bleeding risk during warfarin therapy is associated with the number of variant alleles of CYP2C9 and VKORC1 genes.华法林治疗期间的出血风险与CYP2C9和VKORC1基因的变异等位基因数量有关。
Cardiology. 2013;125(3):182-91. doi: 10.1159/000350407. Epub 2013 Jun 12.
7
The glutathione S-transferase P1 341C>T polymorphism and cancer risk: a meta-analysis of 28 case-control studies.谷胱甘肽 S-转移酶 P1 341C>T 多态性与癌症风险:28 项病例对照研究的荟萃分析。
PLoS One. 2013;8(2):e56722. doi: 10.1371/journal.pone.0056722. Epub 2013 Feb 21.
8
MMP1-1607 1G/2G polymorphism and lung cancer risk: a meta-analysis.基质金属蛋白酶1-1607 1G/2G多态性与肺癌风险:一项荟萃分析。
Tumour Biol. 2012 Dec;33(6):2385-92. doi: 10.1007/s13277-012-0502-4. Epub 2012 Sep 11.
9
Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.ARLTS1 Cys148Arg(T442C)变体与前列腺癌风险的关系及在前列腺癌细胞中的功能。
PLoS One. 2011;6(10):e26595. doi: 10.1371/journal.pone.0026595. Epub 2011 Oct 20.
10
Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.评价 VKORC1 多态性和单倍型、CYP2C9 基因型及临床因素对苏丹患者华法林反应的影响。
Eur J Clin Pharmacol. 2011 Nov;67(11):1119-30. doi: 10.1007/s00228-011-1060-1. Epub 2011 May 18.